Psychotropic medication use, including stimulants, in young children leveling off

The use of psychotropic prescription medications to treat ADHD, mood disorders, anxiety and other mental health disorders in very young children appears to have leveled off.

A national study of 2 to 5 year olds shows that overall psychotropic prescription use peaked in 2002-2005, then leveled off from 2006-2009. The researchers also discovered increased use of these medications among boys, white children and those without during the 16-year study period, 1994-2009.

The Cincinnati Children's Hospital Medical Center study is published online in the journal Pediatrics.

"The likelihood of receiving a behavioral diagnosis increased in 2006 to 2009, but this was not accompanied by an increased propensity toward psychotropic prescription," says Tanya Froehlich, MD, a pediatrician at Cincinnati Children's and the study's senior author. "In fact, the likelihood of psychotropic use in 2006-2009 was half that of the 1994-1997 period among those with a behavioral diagnosis."

Psychotropic usage decreased from 43 percent of those with one or more behavioral diagnoses in 1994-1997 to 29 percent in 2006-2009.

Commonly prescribed psychotropic medications fall into several categories, including both typical and , antidepressants, antianxiety agents, stimulants and mood stabilizers. The U.S. Food and Drug Administration has approved few of these medications for the group, yet previous studies documented two to threefold increases in psychotropic prescriptions for between 1991 and 2001.

The Cincinnati Children's researchers studied data from two national surveys that collect information on patient visits to office-based and hospital-based outpatient clinics throughout the United States. The researchers studied data on more than 43,000 young children.

It is likely that the use of psychotropic medications leveled off due to numerous warnings issued in the mid to late 2000s. These include a 2004 FDA "black box" warning regarding suicidality risk, 2005 public health advisory regarding potential for cardiovascular risks involving amphetamines, and a 2006 FDA Advisory Committee recommendation (later reversed) for a black box warning on psychostimulants linking these drugs to possible heart problems.

Additional research is needed, says Dr. Froehlich, to determine why boys, white children and those without private health insurance are more likely to receive these medications and to determine their appropriateness.

"Our findings underscore the need to ensure that doctors of very young children who are diagnosing ADHD, the most common diagnosis, and prescribing stimulants, the most common psychotropic medications, are using the most up-to-date and stringent diagnostic criteria and clinical practice guidelines," says Dr. Froehlich. "Furthermore, given the continued use of psychotropic medications in very young children and concerns regarding their effects on the developing brain, future studies on the long-term effects of psychotropic medication use in this age group are essential."

add to favorites email to friend print save as pdf

Related Stories

Danish children at risk from psychotropic medicines

Jun 22, 2010

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions (ADRs) in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than h ...

Australians double their antidepressants

Nov 16, 2012

(Medical Xpress)—The use of antidepressants doubled in Australia between 2000 and 2011 and they now account for two out of every three psychotropic medications prescribed, a new study by the University of Sydney reveals.

Recommended for you

Want kids to eat better? Get them cooking

Nov 27, 2014

(HealthDay)—Getting kids involved in the kitchen, through cooking classes or at home, may make them more likely to choose healthy foods, according to a recent review.

Life-saving promise in simple steps

Nov 27, 2014

The debate over the best time to clamp a baby's umbilical cord has been around forever. In about 350 BCE, Aristotle, reputedly the world's first genuine scientist, advocated delaying clamping until placenta ...

PCV13 recommended for 6- to 18-year-olds at high risk

Nov 26, 2014

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.